Cargando…

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement

BACKGROUND: This study was performed to test the hypothesis that expression of small heat shock protein Hsp-27 is, at diagnosis, a reliable predictive biomarker of clinically aggressive prostate cancer. METHODS: A panel of tissue microarrays constructed from a well-characterised cohort of 553 men wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foster, C S, Dodson, A R, Ambroisine, L, Fisher, G, Møller, H, Clark, J, Attard, G, De-Bono, J, Scardino, P, Reuter, V E, Cooper, C S, Berney, D M, Cuzick, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768089/ https://www.ncbi.nlm.nih.gov/pubmed/19707199 http://dx.doi.org/10.1038/sj.bjc.6605227

Ejemplares similares

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
por: Attard, G, et al.
Publicado: (2008)

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
por: Reid, A H M, et al.
Publicado: (2010)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer
por: Ahmad, I, et al.
Publicado: (2013)

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
por: Berney, D M, et al.
Publicado: (2009)

Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
por: Merson, S, et al.
Publicado: (2014)

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
por: Knight, J F, et al.
Publicado: (2008)

Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value
por: Lomnytska, M I, et al.
Publicado: (2011)

Glyoxalase I inhibition induces apoptosis in irradiated MCF-7 cells via a novel mechanism involving Hsp27, p53 and NF-κB
por: Antognelli, C, et al.
Publicado: (2014)

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2012)

DNA methylation gene-based models indicating independent poor outcome in prostate cancer
por: Vasiljević, Nataša, et al.
Publicado: (2014)

The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions
por: Terry, G, et al.
Publicado: (2007)

Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
por: Berney, Daniel M, et al.
Publicado: (2016)

High expression of TROP2 correlates with poor prognosis in pancreatic cancer
por: Fong, D, et al.
Publicado: (2008)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
por: Gupta, A, et al.
Publicado: (2010)

Comparing the performance of six human papillomavirus tests in a screening population
por: Cuzick, J, et al.
Publicado: (2013)

Cortactin expression predicts poor survival in laryngeal carcinoma
por: Gibcus, J H, et al.
Publicado: (2008)

Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer
por: Cristóbal, I, et al.
Publicado: (2014)

Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer
por: Kwon, C H, et al.
Publicado: (2014)

RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH
por: Unger, K, et al.
Publicado: (2006)

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer
por: Preuss, S F, et al.
Publicado: (2008)

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial
por: Pinder, S E, et al.
Publicado: (2010)

Expressions of HSP70 and HSP27 in Hepatocellular Carcinoma
por: Joo, Mee, et al.
Publicado: (2005)

High expression of HSP47 in ulcerative colitis-associated carcinomas: proteomic approach
por: Araki, K, et al.
Publicado: (2009)

The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma
por: Romani, Antonello A, et al.
Publicado: (2007)

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
por: Hussain, S A, et al.
Publicado: (2007)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively
por: Ahmad, Amar S., et al.
Publicado: (2018)

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
por: Popple, A, et al.
Publicado: (2012)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015)

Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer
por: Frietsch, J J, et al.
Publicado: (2010)

High leukocyte mitochondrial DNA content contributes to poor prognosis in glioma patients through its immunosuppressive effect
por: Chen, Y, et al.
Publicado: (2015)

Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients
por: Hinnis, A R, et al.
Publicado: (2007)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2009)

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis
por: Weichert, W, et al.
Publicado: (2007)

Technologies for the diagnosis of angle closure glaucoma (ACE): protocol of a prospective, multicentre, cross-sectional diagnostic study
por: Azuara-Blanco, Augusto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8s97j6oqearfth74vdt9q533t8